Endo to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

Rhea-AI Summary

Endo (OTCQX: NDOI) has announced it will release its fourth quarter and full year 2024 financial results on March 11, 2025, before the market opens. The company will host a conference call at 8:00 a.m. ET on the same day.

Investors can access the audio webcast through the Investor Relations section of Endo's website at investor.endo.com under Events & Presentations. Conference call participants can dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (international). Participants should join 10 minutes before the scheduled start time. A webcast replay will be available after the event.

News Market Reaction – NDOI

+1.61%

+1.61% Session move

In the trading session that priced this news, NDOI gained 1.61%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MALVERN, Pa., Feb. 21, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report fourth quarter and full year 2024 financial results on March 11, 2025, prior to market open. The Company will host a conference call on the same day at 8:00 a.m. ET.

The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.endo.com under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.). Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event.

About Endo
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-11-2025-302382020.html

SOURCE Endo, Inc.

FAQ

When will Endo (NDOI) release its Q4 and full year 2024 earnings?

Endo will release its Q4 and full year 2024 financial results on March 11, 2025, before market open.

What time is Endo's Q4 2024 earnings conference call?

Endo's Q4 2024 earnings conference call is scheduled for March 11, 2025, at 8:00 a.m. ET.

How can investors access Endo's Q4 2024 earnings call?

Investors can access the audio webcast through investor.endo.com under Events & Presentations, or dial 800-836-8184 (U.S./Canada) or 646-357-8785 (international).

Will there be a replay available of Endo's Q4 2024 earnings call?

Yes, a replay of the webcast will be available following the event.